ATLANTA--Ben-Abraham Technologies, a biotechnology company here involved in the development of nanoparticulate technology, will decide within the next few months if it will start a bioinformatics department, according to Claus Wagner-Bartak, the firm's chief operating officer. Ben-Abraham is considering making the move as part of a general expansion of its biotechnology research and development efforts.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.